Ibrutinib Capsule for Blood Cancer

₹ 7,800 - ₹ 7,900 / Bottle

MOQ1 Bottle
Brand NameIbrutinib,Ibrutinib
FormCapsule
Packaging Size30 Capsules,30 Capsules
TreatmentBlood Cancer
Supply TypeExporter, Supplier
Preferred Buyer Location All over the world

Company Information

Member Since 1 Year
Nature of Business Supplier
GST No. 33AAAFS1356F1ZM

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

Packaging Size30 Capsules,30 Capsules
Shelf Life24 Months
Strength140mg
TreatmentBlood Cancer
Country of OriginMade In India
StorageCool Dry Place
Therapeutic UsesTreat Blood Cancer
Side EffectHeadache
ManufacturerCipla
Brand NameIbrutinib,Ibrutinib
FormCapsule
Purity100%

this medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, waldenstrom's macroglobulinemia). ibrutinib belongs to a class of drugs known as kinase inhibitors. it works by slowing or stopping the growth of cancer cellsibrutinib is used to treat chronic lymphocytic leukemia (cll)/small lymphocytic lymphoma (sll), chronic lymphocytic leukemia (cll)/small lymphocytic leukemia (sll) in patients with 17p deletion, and waldenström macroglobulinemia (wm).